164 related articles for article (PubMed ID: 17130792)
1. Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases.
Choukroun G; Thirion M; Lortholary O; Scatton O; Conti F; Calmus Y; Paugam A; Pène F
Transplantation; 2006 Nov; 82(10):1385-6. PubMed ID: 17130792
[No Abstract] [Full Text] [Related]
2. Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
Veroux M; Corona D; Macarone M; Gagliano M; Giuffida G; Veroux P
Nephrol Dial Transplant; 2007 May; 22(5):1487-9. PubMed ID: 17210588
[No Abstract] [Full Text] [Related]
3. Caspofungin versus amphotericin B for invasive candidiasis.
Brown AL; Greig JR
N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
[No Abstract] [Full Text] [Related]
4. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
7. Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination.
Arda B; Soyer N; Sipahi OR; Hüdaverdi O; Tasbakan MI; Saydam G; Tombuloglu M
J Infect; 2006 May; 52(5):387-8. PubMed ID: 16181678
[No Abstract] [Full Text] [Related]
8. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
9. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
10. Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin.
Goicoechea M; Fierer J; Johns S
Clin Infect Dis; 2004 Apr; 38(7):1040-1. PubMed ID: 15034841
[No Abstract] [Full Text] [Related]
11. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
Pelletier R; Alarie I; Lagacé R; Walsh TJ
Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G
Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850
[No Abstract] [Full Text] [Related]
13. Echinocandin antifungal drugs.
Denning DW
Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy.
Fourtounas C; Marangos M; Kalliakmani P; Savidaki E; Goumenos DS; Vlachojannis JG
Nephrol Dial Transplant; 2006 Jan; 21(1):236-7. PubMed ID: 16263742
[No Abstract] [Full Text] [Related]
15. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
17. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
18. A case of candida albicans mediastinitis after heart transplantation successfully treated with caspofungin.
Garlicki M; Czub P; Filczak K; Wojdyga R; Puchniewicz M; Labuś K; Ehrlich MP
Ann Transplant; 2006; 11(1):47-8. PubMed ID: 17025031
[TBL] [Abstract][Full Text] [Related]
19. Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
Kartsonis NA; Saah A; Lipka CJ; Taylor A; Sable CA
J Antimicrob Chemother; 2004 May; 53(5):878-81. PubMed ID: 15044431
[TBL] [Abstract][Full Text] [Related]
20. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
